(Q52930728)

English

Inhibition of bleomycin-induced pulmonary fibrosis by bone marrow-derived mesenchymal stem cells might be mediated by decreasing MMP9, TIMP-1, INF-γ and TGF-β.

scientific article published on 15 July 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

Inhibition of bleomycin-induced pulmonary fibrosis by bone marrow-derived mesenchymal stem cells might be mediated by decreasing MMP9, TIMP-1, INF-γ and TGF-β. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

pulmonary fibrosis

1 reference

based on heuristic

inferred from title

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

author name string

Shi-huan Yu

1

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

Li-jie Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

Bin Lv

3

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

Chun-li Che

4

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

Da-ping Fan

5

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

Li-feng Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

Yi-mei Zhang

7

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

publication date

15 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

Cell Biochemistry & Function

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

33

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

6

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

356-366

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

Integrating mechanisms of pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Side effects of corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Marrow cells as progenitors of lung tissue.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Bone marrow-derived mesenchymal stem cells in repair of the injured lung

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

The effect of Lycium barbarum on spinal cord injury, particularly its relationship with M1 and M2 macrophage in rats

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Matrix metalloproteinase-9 in lung remodeling

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Time course of bleomycin-induced lung fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Differential expression of transforming growth factor-beta type I and II receptors by pulmonary cells in bleomycin-induced lung injury: correlation with repair and fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects

1 reference

https://api.crossref.org/works/10.1002%2FCBF.3118

21 January 2018

Identifiers

10.1002/CBF.3118

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/26178702

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52930728&oldid=1448550192"